
Anaesthesia, Год журнала: 2025, Номер unknown
Опубликована: Янв. 9, 2025
Summary Introduction Glucagon‐like peptide‐1 receptor agonists, dual glucose‐dependent insulinotropic peptide agonists and sodium‐glucose cotransporter‐2 inhibitors are used increasingly in patients receiving peri‐operative care. These drugs may be associated with risks of pulmonary aspiration or euglycaemic ketoacidosis. We produced a consensus statement for the management adults taking these drugs. Methods This multidisciplinary included surgeons, anaesthetists, physicians, pharmacists people lived experience relevant to guidelines. Following directed literature review, three‐round modified Delphi process was conducted generate ratify recommendations. Results Patients glucagon‐like should: continue before surgery; have full risk assessment stratification; receive techniques that mitigate before, during after sedation general anaesthesia. should omit them day procedure. All mitigation strategies discussed shared decision‐making approach. Discussion Until more evidence becomes available, this pragmatic, aims support improve safety period.
Язык: Английский